TD Cowen raised the firm’s price target on Praxis Precision (PRAX) to $554 from $353 and keeps a Buy rating on the shares. The firm updated its model ahead of Q4 results.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PRAX:
- Praxis Precision price target raised to $1,200 from $450 at Piper Sandler
- Praxis Precision management to meet with Jefferies
- Praxis Precision Medicines: Clarified NDA Timelines and Catalyst‑Rich 2026 Underpin Reiterated Buy Rating
- Praxis Precision Medicines: Late-Stage CNS Pipeline and 2026 Catalyst Stack Underpin Reiterated Buy Rating
- Praxis Precision price target raised to $95 from $83 at Wedbush